Disubstituted Bis-Thf Moieties as New P2 Ligands in Non-Peptidal HIV-1 Protease Inhibitors (II).Hohlfeld, K., Wegner, J., Kesteleyn, B., Linclau, B., Unge, J.
(2015) J Med Chem 58: 4029
- PubMed: 25897791
- DOI: https://doi.org/10.1021/acs.jmedchem.5b00358
- Primary Citation of Related Structures:
5AGZ, 5AH6, 5AH7, 5AH8, 5AH9, 5AHA, 5AHB, 5AHC
- PubMed Abstract:
A series of darunavir analogues featuring a substituted bis-THF ring as P2 ligand have been synthesized and evaluated. Very high affinity protease inhibitors (PIs) with an interesting activity on wild-type HIV and a panel of multi-PI resistant HIV-1 mutants containing clinically observed, primary mutations were identified using a cell-based assay. Crystal structure analysis was conducted on a number of PI analogues in complex with HIV-1 protease.
§Lund University, MAX-lab, Ole Römers väg 1, SE-223 63 Lund, Sweden.